权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Development of new cancer immunotherapy using activation of Toll like receptor against gastrointestinal cancer

利用Toll样受体激活对抗胃肠道癌症开发新的癌症免疫疗法

基本信息

批准号：
18591479
负责人：
MATSUDA Kenji
金额：
$ 2.14万
依托单位：
Wakayama Medical University
依托单位国家：
日本
项目类别：
Grant-in-Aid for Scientific Research (C)
财政年份：
2006
资助国家：
日本
起止时间：
2006 至 2007
项目状态：
已结题

来源：
https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-18591479/
关键词：
CDG-ODN peptide immunotherapy

项目摘要

CpG oligodeoxynucleotides (CpG-ODNs) mimic bacterial DNA and induce immune response that comprise innate immunity and acquired Th-1 biased cellular immunity. Recently, 3 types of CpG-ODNs (CpG-A, CpG-B and CpG-C) have been identified based on distinct immunologic activities on human plasmacytoid dendritic cells (PDCs) and B cells. We investigated the activity of these three types of CpG-ODN to enhance the induction of peptide specific CTLs. First, human PBMCs of healthy volunteers were stimulated with each types of CpG-ODN for 48 hours. Samples of the culture media were analyzed for cytokine induction with ELISA method. CpG-A and CpG-C, but not CpG-B, were potent inducers of IFN-α. Second, Flu peptide-specific CTLs were generated from PBMCs cultured with Flu peptide and each types of CpG-ODN for 2 weeks to compare the lytic activity against A24-LCL cells pulsed with Flu peptide in a standard Cr lysis assay. Flu peptide-specific cytotoxicity was enhanced in the presence of each type of CpG-ODN and especially CpG-A and CpG-C showed higher lytic activity than CpG-B. This CpG ODN-induced enhancement of cytotoxicity was disappeared when PDCs were depleted from PBMCs. In conclusion, our results showed that CpG-A and CpG-C might be the superior vaccine adjuvant to CpG-B at least in vitro.

CpG 寡脱氧核苷酸 (CpG-ODN) 模仿细菌 DNA 并诱导免疫反应，包括先天免疫和获得性 Th-1 偏向细胞免疫。最近，基于对人浆细胞样树突状细胞（PDC）和 B 细胞的不同免疫活性，已鉴定出 3 种类型的 CpG-ODN（CpG-A、CpG-B 和 CpG-C）。我们研究了这三种类型的 CpG-ODN 的活性，以增强肽特异性 CTL 的诱导。首先，用每种类型的 CpG-ODN 刺激健康志愿者的人 PBMC 48 小时。使用 ELISA 方法分析培养基样品的细胞因子诱导。 CpG-A 和 CpG-C，但不是 CpG-B，是 IFN-α 的有效诱导剂。其次，用 Flu 肽和每种类型的 CpG-ODN 培养 2 周，从 PBMC 中生成 Flu 肽特异性 CTL，以比较在标准 Cr 裂解测定中用 Flu 肽脉冲的 A24-LCL 细胞的裂解活性。在每种类型的 CpG-ODN 存在下，Flu 肽特异性细胞毒性均增强，尤其是 CpG-A 和 CpG-C 表现出比 CpG-B 更高的裂解活性。当 PBMC 中的 PDC 被耗尽时，这种 CpG ODN 诱导的细胞毒性增强消失。总之，我们的结果表明，至少在体外，CpG-A 和 CpG-C 可能是优于 CpG-B 的疫苗佐剂。